NURS 660 Exam 1 | Questions & 100% Correct Answers (Verified) | Latest Update | Grade A+

Deutetrabenazine (Austedo) : VMAT2- inhibitor -most commonly expected side effects: -drug interactions: -potentially serious adverse events: -FDA indications: Huntington's chorea and TD -lab work that should be monitored prior to starting and while on the medication: Haloperidol (Haldol) : -High potency 1st gen, lacks anticholinergic activity -most commonly expected side effects: high risk for EPS/TD -drug interactions: d/t high potency ^ risk for TD -potentially serious adverse events: prolonged QTc risk (IV admin) -FDA indications: antipscyhotic, reasonable 3rd line p 2 failed SGAs, can augment 2nd gen @ a low dose -1st line as PRN for acute agitation (off-label) -lab work that should be monitored prior to starting and while on the medication: 2 | P a g e Lurasidone (Latuda) : -low metabolic risk, must be taken w/ food (350 cal)- QD dosing -most commonly expected side effects: low sedation risk -drug interactions: Tegretol, St. John's Wort (inducers), grapefruit juice (inhibitor)- could increase dose of med -potentially serious adverse events: poss ^ risk for EPS than the other 'rones' -FDA indications: -lab work that should be monitored prio